-
1 Comment
Medicalgorithmics S.A. is currently in a long term uptrend where the price is trading 27.0% above its 200 day moving average.
Medicalgorithmics S.A.'s total revenue sank by 40.5% to $25M since the same quarter in the previous year.
Its net income has dropped by 4405.0% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 88.8% to $1M since the same quarter in the previous year.
Based on the above factors, Medicalgorithmics S.A. gets an overall score of 1/5.
| Exchange | WAR |
|---|---|
| CurrencyCode | PLN |
| ISIN | PLMDCLG00015 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Target Price | 40.1 |
|---|---|
| Beta | 0.95 |
| Market Cap | 252M |
| PE Ratio | None |
| Dividend Yield | None |
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and reporting; DeepRhythmAI, a AI algorithms device for ECG analysis; and Virtual Cardiac Stress Test, a AI-based medical system for coronary artery atherosclerotic stenosis. The company is developing ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling one-channel offline monitoring; and NextGen, a software version for PocketECG. In addition, it offers information technology, ECG monitoring, and scientific research and development services; and manufactures electrical equipment for medicines. Medicalgorithmics S.A. company was incorporated in 2005 and is headquartered in Warsaw, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MDG.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
